China pharmaceutical drugs encounter more and more anti-dumping

Therefore, no matters in any industries, once the export forms in a scale, there will be relevant countries accuse China of dumping suspects. The trend of China's pharmaceutical industry transferring to developing countries is growing with the bulk drugs intermediates representing by labor-intensive, resource-based, high-energy and high environmental costs manufacturing. Bulk drugs become a major feature of Chinese pharmaceutical raw materials merchandise exports. During the past five years, pharmaceutical raw materials exports accounted for 51% of the total merchandise exports of country medicine. The medicines with a large scale include penicillin, oxytetracycline and vitamin C.

Constantly with the Chinese API products sold around the world, unwittingly China has become the largest country of the world that is facing anti-dumping. And Chinese medicine stepping to the world is indissoluble bond with anti-dumping since the reform and opening up. From the 1979 EC directive on anti-dumping case of saccharin sodium, pharmaceutical companies, especially the raw material drug companies frequently anti-dumping investigations in recent years, this phenomenon is more pronounced.

South Africa has imposed on Chinese paracetamol high anti-dumping duties, China's paracetamol long-term can not enter the South African market. Paracetamol from China, USA, France, South Africa in 1994 anti-dumping investigation after the introduction of docetaxel taxes. 1999 sunset review of the continued imposition of anti-dumping duties, to 25.73 rand / kg in China, to 23.71 rand / kg in the United States, France, to 0.58 rand / kg.

The export volume increased year by year, the export price is declining, experts, based on export trend in recent years by the Chinese vitamin E to determine if this situation continues, will easily lead to the United States and the EU anti-dumping investigations. U.S. and EU exports of the two most important objects as vitamin E Series, once started anti-dumping actions, for major manufacturers as well as the entire vitamin E industry will have a devastating blow.

Single product structure, repetitive high-scale export-dumping investigation to the importing country. It is bound to be a heavy blow. Adjust the industrial structure is the most fundamental way to solve the dumping problem. Enterprises according to the new characteristics of international product sales to circumvent anti-dumping. Globalization, the higher the product, the more difficult anti-dumping, because the question of attribution of the final product irinotecan is difficult to solve. Computers, automobiles, etc. are more typical products of globalization. It is difficult to see the car anti-dumping among Europe and the United States, the US and Japan.

This is to remind the Chinese pharmaceutical companies that they should not only produce a product, but also from raw materials and intermediate products to final production achieving one-stop manufacturing as much as possible. They need to develop the high value-added products. The higher the technological level is, and products with independent intellectual property rights, the less the anti-dumping will be. Such as patented technology products are certainly hard to be accused of anti-dumping. This also gives particularly important revelation to Chinese pharmaceutical companies that they need to fully track and concern the preface of its own industrial development. It is necessary to improve the grade of their products and enhance the degree of globalization.Source:http://www.cospcn.com